New Zealand drugs regulator approves use of MDMA to treat severe PTSD

Sources

Coverage

Limited spectrum

Sentiment

0.00

◀ Left 100%Centre 0%Right 0% ▶

How we rate bias →

This story is currently only covered by one source from a single part of the political spectrum. NewsDeck will update this page automatically if other outlets pick up the story.

shopping_bagDAB Radio

Catch live political coverage and debate shows without needing a screen.

Browse DAB radios on Amazonarrow_forward

NewsDeck Poll

Do you think this story is being covered fairly across the political spectrum?

Loading…

Left

(1)

The Guardian

New Zealand drugs regulator approves use of MDMA to treat severe PTSD

New Zealand decision follows Australian approval in 2023 of psychedelics to treat PTSD and treatment-resistant depression Two psychiatrists in New Zealand won approval on Friday to prescribe pharmaceutical-grade MDMA to people with severe post-traumatic stress disorder (PTSD). The move by New Zealand’s pharmaceutical regulatory body Medsafe makes the country only the second worldwide to approve the party drug for use…